Gene Logic cuts jobs at struggling genomics division

Gene Logic is cutting 80 jobs at its struggling genomics division, saving about $8 million a year in expenses. The division, which has been performing poorly, provides access to gene and toxicogenomics databases. The division has been undergoing an internal evaluation, and there's no guarantee that there won't be more layoffs in the near term.

- see the report on the restructuring from the Washington Business Journal

Suggested Articles

Biogen unveiled full phase 1/2 for a prospect that emerged from a shift in its thinking about treating amyotrophic lateral sclerosis.

It took a little longer than expected, but Biogen’s done it—along with partner Eisai, the Big Biotech has completed an FDA filing for aducanumab.

Gilead is ditching a new avenue of treating hepatitis B as it cuts ties with Precision Biosciences less than two years into their research pact.